PAX Financial Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
PAX Financial Group's ABBV Position: Q3 2026 in Review
PAX Financial Group reduced its AbbVie (ABBV) stake by 8.3% in Q3 2026, selling an estimated $43.1K and leaving 1,851 shares worth $484K. The position accounts for 0.07% of the portfolio, ranked #122.
PAX Financial Group first reported a position in ABBV in Q1 2024 and has held it in 11 quarters since. The position peaked at $572K in Q1 2025. 4,272 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.
- PAX Financial Group held 1,851 shares of AbbVie worth $484K as of Q3 2026.
- PAX Financial Group sold 168 AbbVie shares in Q3 2026, an estimated $43.1K.
- AbbVie made up 0.07% of PAX Financial Group's portfolio in Q3 2026, its #122 holding.
- PAX Financial Group first reported a position in AbbVie in Q1 2024 and has held it in 11 quarters since.
- PAX Financial Group's AbbVie position peaked at $572K in Q1 2025.
- 4,272 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.
Based on PAX Financial Group's 13F filing for Q3 2026, filed 13 Nov 2026.